DHS:NYE-WisdomTree U.S. High Dividend Fund (USD)

ETF | Large Value |

Last Closing

USD 93.8

Change

+0.47 (+0.50)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Large Value

Symbol Name Price(Change) Market Cap
SCHD Schwab U.S. Dividend Equity ET..

+0.27 (+0.32%)

USD 61.23B
DGRO iShares Core Dividend Growth E..

+0.29 (+0.46%)

USD 30.15B
FNDX Schwab Fundamental U.S. Large ..

+0.23 (+0.32%)

USD 17.02B
SCHV Schwab U.S. Large-Cap Value ET..

+0.26 (+0.32%)

USD 11.82B
SPYD SPDR® Portfolio S&P 500 High ..

+0.23 (+0.51%)

USD 6.77B
VOOV Vanguard S&P 500 Value Index F..

+0.85 (+0.45%)

USD 5.21B
FDVV Fidelity® High Dividend ETF

+0.29 (+0.58%)

USD 3.58B
SPHD Invesco S&P 500® High Dividen..

+0.18 (+0.36%)

USD 3.52B
IWX iShares Russell Top 200 Value ..

+0.29 (+0.36%)

USD 3.18B
LRGF iShares U.S. Equity Factor ETF

+0.19 (+0.32%)

USD 2.16B

ETFs Containing DHS

WBAL 0.00 % 0.03 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Large Value) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.14% 31% F 67% D+
Dividend Return 2.94% 89% A- 54% F
Total Return 17.08% 53% F 69% C-
Trailing 12 Months  
Capital Gain 22.31% 7% C- 61% D-
Dividend Return 4.50% 89% A- 59% D-
Total Return 26.81% 13% F 62% D
Trailing 5 Years  
Capital Gain 29.67% 7% C- 60% D-
Dividend Return 18.25% 85% B 63% D
Total Return 47.92% 11% F 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.29% N/A N/A 59% D-
Dividend Return 9.66% N/A N/A 61% D-
Total Return 3.37% N/A N/A 64% D
Risk Return Profile  
Volatility (Standard Deviation) 13.25% N/A N/A 69% C-
Risk Adjusted Return 72.92% N/A N/A 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike